New launches, innovative portfolio set to drive gains for GSK Pharma stock | Markets News
In addition to a strong Q1 show, brokerages expect the company to post strong growth in…
GSK’s RSV Vaccine Arexvy Wins FDA Nod for High-Risk Younger Adults
GSK plc GSK announced that the FDA approved the expanded use of its adjuvanted recombinant respiratory syncytial virus (RSV)…
Japan expands GSK Arexvy RSV vaccine approval to adults 18-49
GSK (NYSE:GSK) announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a label expansion for…